Transition to newer clot-busting drug improves patient outcomes, lowers cost in treating ischemic stroke
Acquired immunity to random food allergens may protect some lucky people against COVID-19
23 September 2022Online atlas shows strong link between gut bacteria and metabolites
23 September 2022Transition to newer clot-busting drug improves patient outcomes, lowers cost in treating ischemic stroke
A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, including better health outcomes and lower costs, according to a new study published today in the American Stroke Association’s journal Stroke.
